Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer

Liao, Xinwen; Fan, Yaqiong; Hou, Jihuan; Chen, Xiong; Xu, Xiaolin; Yang, Yifan; Shen, Jinying; Mi, Panying; Huang, Xiaohua; Zhang, Wenqing; Cao, Hanwei; Hong, Xiaoting; Hu, Tianhui; Zhan, Yan-yan

doi:10.7150/jca.32803



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2019; 10(16):3678-3690. doi:10.7150/jca.32803 This issue Cite

Research Paper

Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer

Xinwen Liao^1,#, Yaqiong Fan^1,#, Jihuan Hou^1,#, Xiong Chen¹, Xiaolin Xu¹, Yifan Yang¹, Jinying Shen¹, Panying Mi¹, Xiaohua Huang², Wenqing Zhang¹, Hanwei Cao¹, Xiaoting Hong², Tianhui Hu¹, Yan-yan Zhan^1,✉

1. Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, Fujian, P.R. China
2. Department of Basic Medicine, School of Medicine, Xiamen University, Xiamen 361102, Fujian, P.R. China
^#These authors contribute equally to this work.

Citation:

Liao X, Fan Y, Hou J, Chen X, Xu X, Yang Y, Shen J, Mi P, Huang X, Zhang W, Cao H, Hong X, Hu T, Zhan Yy. Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer. J Cancer 2019; 10(16):3678-3690. doi:10.7150/jca.32803. https://www.jcancer.org/v10p3678.htm

Other styles

Abstract

Chaetocin, a natural product extracted from Chaetomium species, possesses anticancer effects in several kinds of tumors. However, it remains unclear whether the potential indication for chaetocin could also include human gastric cancer. We found here that chaetocin induced caspase-dependent and -independent apoptosis in human gastric cancer cell lines, which greatly depended on BID-mediated AIF translocation. Despite not increasing the intercellular ROS levels in gastric cancer cells, chaetocin did cause a reduction in mitochondrial membrane potential probably through its regulation on the expression of Bcl-2 and BAX. Chaetocin could also induce autophagy in gastric cancer cells; blocking autophagy by chloroquine enhanced the cytotoxicity of chaetocin. Chaetocin was further found to suppress the growth of gastric cancer xenograft in nude mice. Therefore, our study provides first evidence that chaetocin has an anticancer efficacy against gastric cancer and the combined use of chaetocin with autophagy inhibitors may enhance the therapeutic effect for gastric cancer. As chronic and exorbitant ROS levels instigate drug resistance, chaetocin, which eradicates gastric cancer cells without increasing ROS levels, may initiate a new line of non-ROS-mediated anti-tumor strategy.

Keywords: Chaetocin, gastric cancer, apoptosis, AIF, non-ROS-mediated, autophagy

Citation styles

APA

Liao, X., Fan, Y., Hou, J., Chen, X., Xu, X., Yang, Y., Shen, J., Mi, P., Huang, X., Zhang, W., Cao, H., Hong, X., Hu, T., Zhan, Y.y. (2019). Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer. Journal of Cancer, 10(16), 3678-3690. https://doi.org/10.7150/jca.32803.

ACS

Liao, X.; Fan, Y.; Hou, J.; Chen, X.; Xu, X.; Yang, Y.; Shen, J.; Mi, P.; Huang, X.; Zhang, W.; Cao, H.; Hong, X.; Hu, T.; Zhan, Y.y. Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer. J. Cancer 2019, 10 (16), 3678-3690. DOI: 10.7150/jca.32803.

NLM

CSE

Liao X, Fan Y, Hou J, Chen X, Xu X, Yang Y, Shen J, Mi P, Huang X, Zhang W, Cao H, Hong X, Hu T, Zhan Yy. 2019. Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer. J Cancer. 10(16):3678-3690.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.